GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub

Zacks11-25 21:24

Globus Medical, Inc. GMED recently made a commercial launch of the ExcelsiusHub navigation system. ExcelsiusHub offers advantageous features designed to enhance spine navigation's safety and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486080305?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958","is_english":true,"pubTime":"2024-11-25 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486080305","market":"us","top_or_hot":-1,"title":"GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub","media":"Zacks","content":"<div>\n<p>Globus Medical, Inc. GMED recently made a commercial launch of the ExcelsiusHub navigation system. ExcelsiusHub offers advantageous features designed to enhance spine navigation's safety and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gmed-stock-might-rise-commercial-132400530.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance_au","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-25 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/gmed-stock-might-rise-commercial-132400530.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Globus Medical, Inc. GMED recently made a commercial launch of the ExcelsiusHub navigation system. ExcelsiusHub offers advantageous features designed to enhance spine navigation's safety and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gmed-stock-might-rise-commercial-132400530.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0205194284.USD","symbol_name":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","start_time":0,"source_url":"https://finance.yahoo.com/news/gmed-stock-might-rise-commercial-132400530.html","article_id":"2486080305","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486080305","pubTimestamp":1732541040,"sourceInfo":{"source_id":"yahoofinance_au","name":"Yahoo Finance AU"},"weMediaInfo":null,"summary":"Globus Medical, Inc. GMED recently made a commercial launch of the ExcelsiusHub navigation system. ExcelsiusHub offers advantageous features designed to enhance spine navigation's safety and reproducibility, such as real-time patient array monitoring, tissue-sparing drills and registration flexibility. ExcelsiusHub is an addition to the expansive ecosystem of Excelsius technologies.The latest launch expands the company’s Enabling Technologies product category.Globus Medical is gaining high-level synergy from the continuously increasing adoption of its ExcelsiusGPS robot and Excelsius3D imaging systems in spinal surgery. Additionally, the third quarter of 2024 marked a record for total Excelsius units placed. Moreover, the recent launch of ExcelsiusHub broadens the company’s offering within the intraoperative navigation platform for implant placement accuracy and surgical efficiency space. Accordingly, we expect market sentiment to return in favor of GMED stock in the upcoming days.Per ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","PEN.AU":"PENINSULA ENERGY LTD","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","BK4567":"ESG概念","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","IE0009354923.USD":"JANUS HENDERSON US VENTURE \"A2\" (USD) ACC","BK7007":"医疗保健设备","BK4585":"ETF&股票定投概念","GMED":"Globus Medical Inc","LU2177674079.SGD":"Fidelity Asia Pacific Opportunities A-ACC-SGD (hedged)","BK4082":"医疗保健设备","RMD":"瑞思迈","BK7083":"煤与消费用燃料","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","LU2008162690.USD":"FIDELITY FUNDS - ASIA PACIFIC OPPORTUNITIES \"A\" (USD) ACC","PEN":"Penumbra Inc","BK4198":"医疗保健用品","RMD.AU":"Resmed DRC","BK4588":"碎股","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","BK4504":"桥水持仓","BK7501":"新冠治疗股","BK4548":"巴美列捷福持仓","HAE":"美国血液技术"},"translate_title":"GMED股价可能会因ExcelsiusHub的商业推出而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":1,"PEN.AU":1,"PEN":1,"GMED":1,"HAE":1,"RMD.AU":0.9},"content_text":"Globus Medical, Inc. GMED recently made a commercial launch of the ExcelsiusHub navigation system. ExcelsiusHub offers advantageous features designed to enhance spine navigation's safety and reproducibility, such as real-time patient array monitoring, tissue-sparing drills and registration flexibility. ExcelsiusHub is an addition to the expansive ecosystem of Excelsius technologies.\nThe latest launch expands the company’s Enabling Technologies product category. \nGMED’s Likely Stock Trend Following the News\nSubsequent to the news, GMED's share price moved south 0.6% to $84.24 in aftermarket trading on Friday. \nGlobus Medical is gaining high-level synergy from the continuously increasing adoption of its ExcelsiusGPS robot and Excelsius3D imaging systems in spinal surgery. Additionally, the third quarter of 2024 marked a record for total Excelsius units placed. Moreover, the recent launch of ExcelsiusHub broadens the company’s offering within the intraoperative navigation platform for implant placement accuracy and surgical efficiency space. Accordingly, we expect market sentiment to return in favor of GMED stock in the upcoming days.\nGlobus Medical boasts a market capitalization of $11.54 billion. The company delivered an average earnings surprise of 17.65% in the trailing four quarters.   \nAbout GMED’s ExcelsiusHub\nGlobus Medical’s ExcelsiusHub is designed to elevate the standard for freehand navigation. Freehand navigation provides surgeons with real-time visualization of instrument placement to reduce the reliance on X-ray imaging during spine surgery. This also facilitates the accurate placement of screws and interbody spacer implants and can also reduce OR radiation when compared to conventional fluoroscopy. \nExcelsiusHub offers several differentiated functionalities, including elevated safety features paired with navigational accuracy, designed to enhance patient safety, such as patient array shift tracking and navigation of the DuraPro Oscillating System. It also offers imaging versatility with three distinct workflows — automatic registration with Excelsius3D, CT to fluoroscopy merging, and intraoperative 2D navigation. ExcelsiusHub is designed to navigate best-in-class Globus Medical instruments and implants for a complete procedural solution from the cervical spine to the sacrum.\nExcelsiusHub supports a variety of procedures, from minimally invasive to complex spinal deformity surgeries. Moreover, the newly launched ExcelsiusHub is a technological enhancement aimed at improving efficiency in operating rooms and surgical solutions for patients.\nIndustry Prospects Favor GMED\nPer a report by Insight Partners, the surgical navigation systems market size is expected to grow $2.46 billion by 2030 at a compound annual growth rate of 10.09% from 2022 to 2030. Key factors responsible for market growth include the expanding demand for robot-assisted surgery, the growing need for minimally invasive surgical procedures and the rising prevalence of target disorders. \nImage Source: Zacks Investment Research\nAnother Recent Development by GMED\nThe previous month, Globus Medical reported the expansion of its rapidly growing orthopedic trauma product portfolio. The newly launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. With these newly launched next-gen products, the company now has more capacity to serve a wide variety of patient needs depending upon its new technologies building out the orthopedic trauma product portfolio.\nGMED’s Share Price Performance\nIn the past year, GMED’s shares have risen 83.9% compared with the industry’s 14.8% growth.\nGMED’s Zacks Rank and Other Key Picks\nGlobus Medical currently carries a Zacks Rank #2 (Buy).\nSome other top-ranked stocks in the broader medical space are Haemonetics HAE, Penumbra PEN, and ResMed RMD. While ResMed sports a Zacks Rank #1 (Strong Buy) at present, Haemonetics and Penumbra carry a Zacks Rank #2 each. You can see the complete list of today’s Zacks #1 Rank stocks here.\nHaemonetics has an earnings yield of 5.02% compared with the industry’s 1.18%. Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 19.39%. Its shares have risen 1.8% compared with the industry’s 23.1% growth in the past year. Estimates for Haemonetics’ 2025 EPS have moved north 0.4% to $4.59 in the past 30 days. \nEstimates for Penumbra’s 2024 EPS have moved north 8.1% to $2.79 in the past 30 days. Shares of the company have surged 60.6% in the past year compared with the industry’s growth of 32.7%. PEN’s earnings surpassed estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 10.54%.\nEstimates for ResMed’s fiscal 2025 EPS have risen 2.7% in the past 30 days. Shares of the company have surged 86.3% in the past year compared with the industry’s 32.1% growth. RMD’s earnings surpassed estimates in each of the trailing four quarters, the average beat being 6.4%. In the last reported quarter, it delivered an earnings surprise of 8.4%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nResMed Inc. (RMD) : Free Stock Analysis Report\nHaemonetics Corporation (HAE) : Free Stock Analysis Report\nGlobus Medical, Inc. (GMED) : Free Stock Analysis Report\nPenumbra, Inc. (PEN) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486080305"}